Aurobindo Pharma Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth observed, with a rise from ₹6,850.52 crore to ₹7,796.07 crore in the latest quarter.
Net profit increased significantly to ₹816.95 crore, affirming strong operational efficiency and cost management.
Operating profit margin (OPM) remained stable, indicating effective control over operational expenses.

NEGATIVES

Profit before tax decreased slightly from ₹1,323.89 crore to ₹1,207.46 crore, reflecting potential challenges in maintaining profitability.
Decline in other income, primarily driven by reduced exceptional items, impacting overall income stability.
Interest expenses increased, suggesting potential pressure on future profitability if not managed effectively.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	6,850.52	7,219.42	7,351.78	7,580.15	7,567.02	7,796.07	7,978.52	7,868.14
Expenses	6,082.26	6,331.66	6,249.29	6,351.10	6,462.67	6,724.91	6,937.55	6,768.56
Operating Profit	768.26	887.76	1,102.49	1,229.05	1,104.35	1,071.16	1,040.97	1,099.58
Other Income	116.33	186.98	162.52	135.62	220.93	136	157.29	105.30
Interest	56.55	68.18	75.55	89.43	111.04	112.70	118.48	97.75
Depreciation	326.56	417.50	423.27	354.33	404.18	382.28	418.53	405.70
Profit Before Tax	812.03	1,075.64	1,262.42	1,229.90	1,323.89	1,207.46	1,199.85	1,206.80
Tax	242.32	323.70	322.45	322.55	405.67	390.51	354.28	382.60
Net Profit	569.71	751.94	939.97	907.35	918.22	816.95	845.57	824.20
Eps in Rs	9.74	12.83	16.04	15.51	15.69	14	14.56	14.20